OKTA vs VERA · P/E 84, rev $1.57B vs $2.51B cap
Okta Inc (OKTA) versus Vera Therapeutics Inc (VERA) — a side-by-side from cached financials, not a winner call.
Okta Inc (OKTA) is a software - infrastructure company listed on NASDAQ.
Vera Therapeutics Inc (VERA) is a biotechnology company listed on NASDAQ.
Latest reported OKTA revenue for 2026-07-31 was $1.57B. Net income was $190.0M. OKTA currently screens at market cap $20.06B and trailing P/E 83.6.
VERA does not have a complete income-statement cache yet.
OKTA currently screens at market cap $20.06B and trailing P/E 83.6. VERA currently screens at market cap $2.51B.
Not investment advice. Open the OKTA and VERA stock pages for the full models.
Not investment advice.